Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin)

Clinical trial NCT00635193 · COMPLETED

Trial details

NCT number: NCT00635193
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer, Primary Peritoneal Cancer

Start date: 2007-07-01
Primary completion: 2008-10-01
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.